Published in Proc Natl Acad Sci U S A on September 03, 1996
Regulation of human immunodeficiency virus replication by 2',5'-oligoadenylate-dependent RNase L. J Virol (1998) 1.02
AIDS vaccine development: let a thousand flowers bloom. J Clin Pathol (1998) 0.75
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res (1987) 36.83
Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell (1991) 13.69
Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1. Proc Natl Acad Sci U S A (1981) 10.04
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science (1995) 10.02
Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science (1992) 9.30
Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med (1995) 8.15
Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science (1990) 8.07
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science (1995) 6.30
The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses (1990) 5.79
In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (1992) 5.47
The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med (1994) 5.22
Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci U S A (1991) 4.23
Progression to AIDS in the absence of a gene for vpr or vpx. J Virol (1995) 3.96
Clearance of HIV infection in a perinatally infected infant. N Engl J Med (1995) 3.76
Present status of attenuated live-virus poliomyelitis vaccine. J Am Med Assoc (1956) 3.61
A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature (1992) 3.59
Origin, Kinetics, and characteristics of pulmonary macrophages in the normal steady state. J Exp Med (1979) 3.57
Time to hit HIV, early and hard. N Engl J Med (1995) 3.53
Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology (1994) 3.16
Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science (1994) 2.79
Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry. J Virol (1993) 2.70
Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis (1995) 2.65
Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. J Virol (1995) 2.43
Fidelity of HIV-1 reverse transcriptase copying RNA in vitro. Biochemistry (1992) 2.27
The relationship of IL-4- and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Cell (1993) 2.19
Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J Virol (1994) 2.07
A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol (1995) 1.71
Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac. J Virol (1991) 1.71
Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci U S A (1993) 1.63
Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Clin Pharmacol Ther (1993) 1.47
Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci U S A (1994) 1.46
Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci U S A (1994) 1.34
Identification of a common clonal human immunodeficiency virus integration site in human immunodeficiency virus-associated lymphomas. Cancer Res (1994) 1.12
The nef gene from a long-term HIV type 1 nonprogressor. AIDS Res Hum Retroviruses (1996) 1.11
Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine. AIDS Res Hum Retroviruses (1994) 1.03
Cell kinetics of pulmonary alveolar macrophages in the mouse. Cell Tissue Kinet (1982) 0.97
Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function. Proc Natl Acad Sci U S A (1996) 0.94
The selective ablation of interleukin 2-producing cells isolated from transgenic mice. J Exp Med (1993) 0.91
Inhibition of herpes virus by a new compound--acyclic guanosine. J Antimicrob Chemother (1979) 0.88
Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc Natl Acad Sci U S A (1994) 0.88
Vaccines for varicella-zoster virus and cytomegalovirus: recent progress. Science (1994) 0.83
HIV with multiple gene deletions as a live attenuated vaccine for AIDS. AIDS Res Hum Retroviruses (1992) 0.80
Attenuated retrovirus vaccines and AIDS. Science (1995) 0.79
Acyclovir for suspected systemic herpes infections. Lancet (1980) 0.78
The enigma of HIV infection. Cell (1995) 0.78
Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. The Cardiac Transplant Research Database Group. J Heart Lung Transplant (1994) 0.78
Does HIV infection of B lymphocytes initiate AIDS lymphoma? Detection by PCR of viral sequences in lymphoma tissue. Curr Top Microbiol Immunol (1992) 0.77
Significance of premature stop codons in env of simian immunodeficiency virus. J Virol (1989) 3.60
Simian immunodeficiency virus from African green monkeys. J Virol (1988) 2.65
Human immunodeficiency virus rev protein recognizes a target sequence in rev-responsive element RNA within the context of RNA secondary structure. J Virol (1990) 1.94
Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Res (1992) 1.89
Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA. J Biol Chem (1997) 1.77
Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene. J Virol (1994) 1.77
Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science (1994) 1.72
Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera. Proc Natl Acad Sci U S A (1993) 1.19
Rev-induced modulation of Nef protein underlies temporal regulation of human immunodeficiency virus replication. Proc Natl Acad Sci U S A (1989) 1.18
The nef gene from a long-term HIV type 1 nonprogressor. AIDS Res Hum Retroviruses (1996) 1.11
Gastric carcinoma. Study of lymphatic metastasis. Chin Med J (Engl) (1984) 1.09
Molecular changes associated with replication of simian immunodeficiency virus in human cells. J Med Primatol (1990) 0.96
Selective RNA cleavage by isolated RNase L activated with 2-5A antisense chimeric oligonucleotides. Methods Enzymol (2000) 0.88
Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L. J Med Chem (1997) 0.80
Growth properties of HSIVnef: HIV-1 containing the nef gene from pathogenic molecular clone SIVmac239. Virus Res (1998) 0.79
Nuclease-resistant composite 2',5'-oligoadenylate-3', 5'-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisense. J Med Chem (1998) 0.79
Attenuated retrovirus vaccines and AIDS. Science (1995) 0.79
2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells. Blood (1998) 0.78
Mice transgenic for simian immunodeficiency virus nef are immunologically compromised. J Biomed Sci (1998) 0.76
Animal models for AIDS pathogenesis. Adv Pharmacol (2000) 0.76
Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense. Antivir Chem Chemother (1998) 0.76
[An investigation on menstruation of 2,295 high altitude women native of Qinghai (author's transl)]. Zhonghua Fu Chan Ke Za Zhi (1981) 0.75
Nonhuman primate lentiviruses: models for human infection. Dev Biol Stand (1990) 0.75
Dominant factor determining the conduction-type of nitrogen-doped ZnO film. J Nanosci Nanotechnol (2014) 0.75
[Study of reforming the nursing management in our hospital]. Zhonghua Hu Li Za Zhi (1995) 0.75